Literature DB >> 22767611

Discovery of regulators of receptor internalization with high-throughput flow cytometry.

Yang Wu1, Phillip H Tapia, Gregory W Fisher, Peter C Simons, J Jacob Strouse, Terry Foutz, Alan S Waggoner, Jonathan Jarvik, Larry A Sklar.   

Abstract

We developed a platform combining fluorogen-activating protein (FAP) technology with high-throughput flow cytometry to detect real-time protein trafficking to and from the plasma membrane in living cells. The hybrid platform facilitates drug discovery for trafficking receptors such as G protein-coupled receptors and was validated with the β₂-adrenergic receptor (β₂AR) system. When a chemical library containing ∼1200 off-patent drugs was screened against cells expressing FAP-tagged β₂ARs, all 33 known β₂AR-active ligands in the library were successfully identified, together with a number of compounds that might regulate receptor internalization in a nontraditional manner. Results indicated that the platform identified ligands of target proteins regardless of the associated signaling pathway; therefore, this approach presents opportunities to search for biased receptor modulators and is suitable for screening of multiplexed targets for improved efficiency. The results revealed that ligands may be biased with respect to the rate or duration of receptor internalization and that receptor internalization may be independent of activation of the mitogen-activated protein kinase pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22767611      PMCID: PMC3463215          DOI: 10.1124/mol.112.079897

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  55 in total

Review 1.  How many drug targets are there?

Authors:  John P Overington; Bissan Al-Lazikani; Andrew L Hopkins
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

Review 2.  Cell-based high-content screening of small-molecule libraries.

Authors:  Kerstin Korn; Eberhard Krausz
Journal:  Curr Opin Chem Biol       Date:  2007-10-10       Impact factor: 8.822

3.  Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.

Authors:  David Centurión; Suneet Mehotra; Araceli Sánchez-López; Saurabh Gupta; Antoinette MaassenVanDenBrink; Carlos M Villalón
Journal:  Eur J Pharmacol       Date:  2006-03-20       Impact factor: 4.432

4.  Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.

Authors:  A Tunek; L A Svensson
Journal:  Drug Metab Dispos       Date:  1988 Sep-Oct       Impact factor: 3.922

5.  Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists.

Authors:  M Isogaya; Y Sugimoto; R Tanimura; R Tanaka; H Kikkawa; T Nagao; H Kurose
Journal:  Mol Pharmacol       Date:  1999-11       Impact factor: 4.436

6.  beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.

Authors:  Sudha K Shenoy; Matthew T Drake; Christopher D Nelson; Daniel A Houtz; Kunhong Xiao; Srinivasan Madabushi; Eric Reiter; Richard T Premont; Olivier Lichtarge; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2005-11-09       Impact factor: 5.157

7.  Levobetaxolol (Betaxon) and other beta-adrenergic antagonists: preclinical pharmacology, IOP-lowering activity and sites of action in human eyes.

Authors:  N A Sharif; S X Xu; J Y Crider; M McLaughlin; T L Davis
Journal:  J Ocul Pharmacol Ther       Date:  2001-08       Impact factor: 2.671

8.  Potent and selective human beta(3)-adrenergic receptor antagonists.

Authors:  M R Candelore; L Deng; L Tota; X M Guan; A Amend; Y Liu; R Newbold; M A Cascieri; A E Weber
Journal:  J Pharmacol Exp Ther       Date:  1999-08       Impact factor: 4.030

Review 9.  Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.

Authors:  Donald P Tashkin; Leonardo M Fabbri
Journal:  Respir Res       Date:  2010-10-29

10.  Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.

Authors:  Mounia Azzi; Pascale G Charest; Stéphane Angers; Guy Rousseau; Trudy Kohout; Michel Bouvier; Graciela Piñeyro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-17       Impact factor: 11.205

View more
  11 in total

1.  Fluorogen-activating-proteins as universal affinity biosensors for immunodetection.

Authors:  Eugenio Gallo; Kalin V Vasilev; Jonathan Jarvik
Journal:  Biotechnol Bioeng       Date:  2013-11-14       Impact factor: 4.530

2.  Breaking the color barrier - a multi-selective antibody reporter offers innovative strategies of fluorescence detection.

Authors:  Eugenio Gallo; Jonathan W Jarvik
Journal:  J Cell Sci       Date:  2017-06-14       Impact factor: 5.285

Review 3.  Dark dyes-bright complexes: fluorogenic protein labeling.

Authors:  Marcel P Bruchez
Journal:  Curr Opin Chem Biol       Date:  2015-06-06       Impact factor: 8.822

4.  Antibody-Linked Fluorogen-Activating Proteins for Antigen Detection and Cell Ablation.

Authors:  Daniel S Ackerman; Burcin Altun; Dmytro Kolodieznyi; Marcel P Bruchez; Andrew Tsourkas; Jonathan W Jarvik
Journal:  Bioconjug Chem       Date:  2018-12-26       Impact factor: 4.774

5.  Real-time detection of protein trafficking with high-throughput flow cytometry (HTFC) and fluorogen-activating protein (FAP) base biosensor.

Authors:  Yang Wu; Phillip H Tapia; Jonathan Jarvik; Alan S Waggoner; Larry A Sklar
Journal:  Curr Protoc Cytom       Date:  2014-01-02

6.  High-throughput flow cytometry compatible biosensor based on fluorogen activating protein technology.

Authors:  Yang Wu; Phillip H Tapia; Gregory W Fisher; Alan S Waggoner; Jonathan Jarvik; Larry A Sklar
Journal:  Cytometry A       Date:  2013-01-09       Impact factor: 4.355

7.  Malachite green mediates homodimerization of antibody VL domains to form a fluorescent ternary complex with singular symmetric interfaces.

Authors:  Chris Szent-Gyorgyi; Robyn L Stanfield; Susan Andreko; Alison Dempsey; Mushtaq Ahmed; Sarah Capek; Alan S Waggoner; Ian A Wilson; Marcel P Bruchez
Journal:  J Mol Biol       Date:  2013-08-23       Impact factor: 5.469

Review 8.  Fluorogenic Labeling Strategies for Biological Imaging.

Authors:  Chenge Li; Alison G Tebo; Arnaud Gautier
Journal:  Int J Mol Sci       Date:  2017-07-09       Impact factor: 5.923

9.  Effect of human cytomegalovirus (HCMV) US27 on CXCR4 receptor internalization measured by fluorogen-activating protein (FAP) biosensors.

Authors:  Jordan M Boeck; Juliet V Spencer
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

10.  Enhancing Cancer Drug Discovery through Novel Cell Signaling Pathway Panel Strategy.

Authors:  Liang Schweizer; Litao Zhang
Journal:  Cancer Growth Metastasis       Date:  2013-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.